Aprea Therapeutics Inc

NASDAQ:APRE   3:28:45 PM EDT
4.22
-0.12 (-2.76%)
Earnings Announcements

Aprea Therapeutics Q4 Loss Per Share $0.73

Published: 03/16/2021 21:04 GMT
Aprea Therapeutics Inc (APRE) - Aprea Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Update on Business Operations.
Q4 Loss per Share $0.73.
Q4 Earnings per Share Estimate $-0.64 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.